Back to Search
HANS LILJA, MD, PHD
MD, PHD
Chemistry Pathology Specialist/Technologist
NPI: 1609180025Individual
Specialties, Licenses & Credentials
Chemistry Pathology Specialist/TechnologistPrimary
Specialist/Technologist, Pathology — Chemistry
Code: 246QC1000X
Research & Publications (20)
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
PMID 18337732·Nat Rev Cancer·2008
6-review
Can PSA velocity predict risk of death in men with prostate cancer?
PMID 17519910·Nat Clin Pract Urol·2007
8-other
NF-kappaB regulates androgen receptor expression and prostate cancer growth.
PMID 19628766·Am J Pathol·2009
7-preclinical
Screening and prostate-cancer mortality in a randomized European study.
PMID 19297566·N Engl J Med·2009
4-observational
Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
PMID 19578355·Nat Rev Urol·2009
6-review
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
PMID 19660851·Eur Urol·2009
8-other
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
PMID 19116992·Prostate·2009
8-other
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.
PMID 19318948·Curr Opin Urol·2009
6-review
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort.
PMID 19682790·Eur Urol·2009
8-other
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer.
PMID 19276271·Clin Cancer Res·2009
8-other
Early versus delayed oxytocin augmentation in nulliparous women with prolonged labour--a randomised controlled trial.
PMID 19250364·BJOG·2009
4-observational
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.
PMID 19233911·Clin Chem·2009
8-other
Increase in percent free prostate-specific antigen in men with chronic kidney disease.
PMID 19028756·Nephrol Dial Transplant·2009
8-other
Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.
PMID 19064972·J Clin Oncol·2009
1-meta
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
PMID 19506163·J Clin Oncol·2009
8-other
Test sensitivity in the European prostate cancer screening trial: results from Finland, Sweden, and the Netherlands.
PMID 19567505·Cancer Epidemiol Biomarkers Prev·2009
2-rct
Cutpoints in clinical chemistry: time for fundamental reassessment.
PMID 19028819·Clin Chem·2009
8-other
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
PMID 19003994·Int J Cancer·2009
8-other
Acoustic whole blood plasmapheresis chip for prostate specific antigen microarray diagnostics.
PMID 19594154·Anal Chem·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE # 213
NEW YORK, NY 10065 - Phone
- (212) 639-6982
Quick Facts
- NPI
- 1609180025
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile